EYEPOINT PHARMACEUTICALS INC's ticker is EYPT and the CUSIP is 30233G209. A total of 93 filers reported holding EYEPOINT PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,143,377 | +296.7% | 476,250 | +842.5% | 0.03% | +366.7% |
| Q1 2024 | $1,044,513 | -16.3% | 50,533 | -6.5% | 0.01% | -25.0% |
| Q4 2023 | $1,248,448 | +15.6% | 54,022 | -60.0% | 0.01% | 0.0% |
| Q3 2023 | $1,079,920 | +263.2% | 135,159 | +295.4% | 0.01% | +300.0% |
| Q2 2023 | $297,357 | +614.8% | 34,179 | +187.6% | 0.00% | – |
| Q4 2022 | $41,601 | -56.7% | 11,886 | -2.2% | 0.00% | -100.0% |
| Q3 2022 | $96,000 | +84.6% | 12,152 | +84.1% | 0.00% | – |
| Q2 2022 | $52,000 | -5.5% | 6,600 | +46.6% | 0.00% | – |
| Q1 2022 | $55,000 | -41.5% | 4,501 | -41.6% | 0.00% | -100.0% |
| Q4 2021 | $94,000 | -52.0% | 7,709 | -59.9% | 0.00% | -66.7% |
| Q1 2021 | $196,000 | – | 19,243 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Essex Woodlands Management, Inc. | 1,551,521 | $13,498,233 | 4.40% |
| Cormorant Asset Management, LP | 8,325,000 | $72,427,500 | 4.18% |
| ORACLE INVESTMENT MANAGEMENT INC | 231,857 | $2,017,156 | 1.88% |
| Finepoint Capital LP | 707,404 | $6,154,415 | 1.75% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 5,175,823 | $45,029,660 | 1.65% |
| Octagon Capital Advisors LP | 1,093,503 | $9,513,476 | 1.50% |
| TCG Crossover Management, LLC | 922,335 | $8,024,315 | 0.84% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 37,838 | $329,191 | 0.42% |
| Corton Capital Inc. | 49,905 | $434,174 | 0.23% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 100,000 | $870,000 | 0.20% |